Ventus Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Ventus Therapeutics is a biotechnology research company based in Waltham, Massachusetts, with a workforce of 51 to 200 employees. The company utilizes a structure-based drug discovery approach through its ReSOLVE platform, integrating computational tools with world-class structural biology and chemistry to target biologically validated but difficult-to-drug proteins. ReSOLVE aims to reveal previously unknown pockets, better characterize known pockets, and address limitations in virtual screening to accelerate medicinal chemistry and SAR optimization. The company maintains a pipeline of small-molecule candidates for autoimmune and inflammatory diseases, neurological disorders, and cancer, and also develops a library of chemical matter for elusive targets. In 2025, Ventus announced it is a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs and entered into a collaboration with Genentech to discover and optimize novel small-molecule candidates using ReSOLVE. In 2024, Ventus expanded its presence with a new laboratory and office facility in Montréal, Canada.

Get verified Ventus Therapeutics emails free

Company overview Employee directory